Skip to content

Understanding Your Laboratory Test: A Patient Guide

Published: August 9, 2026Updated: August 16, 2026

This blood or bone marrow test checks for a specific genetic mutation (c.944C>T) in the ABL1 gene that may affect leukemia treatment response.

Quick summary

{"Detects a specific genetic change (c.944C>T) in the ABL1 gene","Helps doctors determine if certain leukemia treatments will work","Requires a blood or bone marrow sample","Results guide personalized treatment decisions","Also known as T315I mutation, associated with treatment resistance"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
95550-0
Short code
ABL1 c.944C>T
Synonyms
ABL1 c.944C>T Bld/Mar Ql
Category
chemistry
Sample
whole-blood
Container
EDTA tube (Lavender top - K2EDTA or K3EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
0–120 years
Method
molgen
CPT
81206
SNOMED
371468004
Specimen volume
2-5 mL whole blood; 1-2 mL minimum acceptable
Stability
Room temperature: 24-72 hours; Refrigerated (2-8°C): up to 7 days; Frozen (-20°C or below): acceptable for extended storage but avoid repeated freeze-thaw cycles
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
72–168 hours
Order
routine

This test is a laboratory or diagnostic procedure that helps your doctor measure specific substances or check how certain parts of your body are working. The results provide important information about your overall health and help guide decisions about your care.

The ABL1 gene c.944C>T test is a molecular genetic test that looks for a specific mutation (change) in the ABL1 gene. This gene provides instructions for making a protein involved in cell growth and division. The c.944C>T mutation creates a specific change in the ABL1 protein (known as T315I), which can affect how certain cancer medications work.

Your doctor may order this test to look for a medical condition, monitor a health problem you already have, or see how well a treatment is working. It can also be part of a routine checkup to find potential issues early, before symptoms appear.

Your doctor may order this test if you have been diagnosed with leukemia, particularly chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). This test helps determine whether the leukemia cells carry the c.944C>T (T315I) mutation, which can make certain targeted therapies less effective. The results help your doctor choose the most appropriate treatment for your specific condition.

The test is usually performed by a trained healthcare professional in a clinic, hospital, or laboratory. Depending on the type of test, a small sample of blood, urine, or other body material may be collected, or a scanning device may be used. The procedure is typically quick and straightforward.

The test requires a sample of your blood or bone marrow. For a blood test, a healthcare provider will draw blood from a vein in your arm. For a bone marrow test, a small sample of liquid bone marrow is collected from your hip bone using a thin needle. The sample is then sent to a laboratory where scientists use specialized molecular techniques to look for the c.944C>T mutation in the ABL1 gene.

Your results will be compared with standard reference ranges. Values within the normal range usually suggest no abnormality, while values that are too high or too low may point to a condition that needs further evaluation. Your doctor will explain what your specific results mean and what the next steps may be.

Results are typically reported as 'Present' (mutation detected) or 'Absent' (mutation not detected). If the mutation is present, it may indicate that standard tyrosine kinase inhibitor (TKI) therapies like imatinib may not work as well. Your doctor will use this information, along with other test results and your overall health, to determine the best treatment plan. A negative result suggests that standard treatments may be more likely to be effective.

Most tests are very safe. If a blood sample is taken, you may feel a brief sting and notice slight bruising or soreness at the needle site. Serious complications are rare. Contact your doctor if you experience unusual pain, swelling, bleeding, or signs of infection afterward.

The risks associated with blood collection are minimal and may include slight pain, bruising, or bleeding at the needle site. Bone marrow collection may cause temporary discomfort or bruising at the collection site. These procedures are generally safe and are performed by experienced healthcare professionals.

Reference range

Not Detected / Absent - The c.944C>T variant in ABL1 gene should not be present in the germline DNAN/A

Specimen: whole-blood

No special preparation required. Standard venipuncture precautions apply. Inform the laboratory of any recent blood transfusions as this may affect results.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The ABL1 c.944C>T (T315I) mutation is clinically significant because it is associated with resistance to first-generation and second-generation tyrosine kinase inhibitors (TKIs) used to treat CML and Philadelphia chromosome-positive ALL. Detection of this mutation may lead to consideration of alternative treatments such as ponatinib, which is specifically active against the T315I mutation. This test is also important for monitoring disease progression and guiding treatment decisions throughout therapy.

Frequently asked questions

How long does it take to get results?
Molecular genetic tests like this one typically take 1-2 weeks to complete. The sample needs to be processed in a specialized laboratory that performs genetic testing.
Do I need to fast before this test?
No fasting is required for either blood or bone marrow collection. You can eat and drink normally before the test.
Can this test tell me if my cancer is cured?
No, this test does not determine cure. It helps guide treatment decisions by identifying whether a specific genetic mutation is present that may affect how well certain medications work. Your doctor will use this information along with other tests to monitor your condition.
Will I need to have this test again?
Your doctor may order this test multiple times during your treatment to monitor for the emergence of resistant mutations or to assess how well treatment is working. The frequency depends on your specific condition and treatment plan.
Does having this mutation mean my cancer is worse?
Not necessarily. The presence of the c.944C>T mutation means that certain standard treatments may be less effective, but there are alternative treatments available that work specifically against this mutation. Your doctor will discuss the best treatment options with you.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy